Condition 1: Postmenopausal women’s sexual function. Condition 2: Severity of postmenopausal symptoms. Menopausal and female climacteric states
Conditions
Interventions
Intervention 1: Intervention group: Oral asparagus officinalis capsules, each capsules contains 500 mg asparagus officinalis, 3 capsules daily (One every 8 hours) for 8 weeks, constructed by Faculty o
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Being Iranian At least they should be able to read and write At least one year has passed since the last menstruation Being in the first five years of menopause Have sexual activity in the last 6 months Menopause occurs naturally (not followed by oophorectomy)
Exclusion criteria
Exclusion criteria: Taking medications such as vitamin K and potassium Using chemical or herbal drug (ginseng, vitagenus, maca, femexite capsule, flibanserin) effective on sexual function (according to the self-report) Suffering from diseases that affect sexual function such as musculoskeletal diseases, multiple sclerosis, endometriosis, diabetes, hypertension (according to the self-report) Taking hormone replacement therapy Their spouses suffer from sexual problems such as erectile dysfunction or premature ejaculation (according to the self-report) History of surgeries such as hysterectomy, oophorectomy, cystocele and rectocele, and mastectomy The presence of known psychological disorders in women and their spouses (according to the self-report) Addiction to cigarettes, alcohol or drugs Suffering from kidney diseases, chronic diarrhea and diseases that lead to malabsorption (celiac, Crohn's disease) (according to the self-report) History of fibroids or problems such as breast cancer Presence of specific events or incidents that represents a crisis in their life, such as death or incurable illness of family members, change of residence, loss of job since 6 months ago and marital infidelity, and being on the verge of divorce The occurrence of premature menopause The occurrence of speech, hearing or mental disorders that prevent communication with the researcher
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual function. Timepoint: Before the intervention, at the end of the intervention and 4 weeks later. Method of measurement: Female sexual function index.;Severity of postmenopausal symptoms. Timepoint: Before the intervention, at the end of the intervention and 4 weeks later. Method of measurement: Menopause rating scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMobina Mehrzad
Shahid Beheshti University of Medical Sciences
Outcome results
None listed